Results 221 to 230 of about 52,965 (242)
Some of the next articles are maybe not open access.
Clinical Drug Investigation, 2007
Irritable bowel syndrome (IBS) is a disease of unclear, complex pathophysiology characterised by abdominal pain and discomfort and altered bowel activity. It affects an estimated 10-15% of individuals worldwide and has a large impact on quality of life (QOL) and both direct and indirect healthcare costs.
openaire +2 more sources
Irritable bowel syndrome (IBS) is a disease of unclear, complex pathophysiology characterised by abdominal pain and discomfort and altered bowel activity. It affects an estimated 10-15% of individuals worldwide and has a large impact on quality of life (QOL) and both direct and indirect healthcare costs.
openaire +2 more sources
Regulating protease homeostasis in irritable bowel syndrome
Nature Reviews Gastroenterology and Hepatology, 2022Katrina Ray
exaly
Unravelling the genetics of irritable bowel syndrome
Nature Reviews Gastroenterology and Hepatology, 2021Katrina Ray
exaly
Abdominal pain in irritable bowel syndrome
Nature Reviews Gastroenterology and Hepatology, 2022Nathalie Vergnolle, Vergnolle Nathalie
exaly
Immune activation in irritable bowel syndrome: what is the evidence?
Nature Reviews Immunology, 2022Hind Hussein +2 more
exaly
Irritable bowel syndrome and mental health comorbidity — approach to multidisciplinary management
Nature Reviews Gastroenterology and Hepatology, 2023Christopher Black +2 more
exaly
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome
Nature Reviews Gastroenterology and Hepatology, 2022Keith Sharkey +2 more
exaly
Global burden of irritable bowel syndrome: trends, predictions and risk factors
Nature Reviews Gastroenterology and Hepatology, 2020Christopher Black +2 more
exaly